Cargando…
Atrial fibrillation in patients with ischemic stroke: A population-based study
BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outc...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943164/ https://www.ncbi.nlm.nih.gov/pubmed/20865087 |
_version_ | 1782187002803781632 |
---|---|
author | Thygesen, Sandra Kruchov Frost, Lars Eagle, Kim A Johnsen, Søren Paaske |
author_facet | Thygesen, Sandra Kruchov Frost, Lars Eagle, Kim A Johnsen, Søren Paaske |
author_sort | Thygesen, Sandra Kruchov |
collection | PubMed |
description | BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outcomes in a cohort of first-time ischemic stroke patients with and without atrial fibrillation. METHODS: Based on linkage of public medical databases, we did a population-based follow-up study among 3,849 stroke patients from the County of Aarhus, Denmark admitted in the period of 2003–2007 and prospectively registered in the Danish National Indicator Project. RESULTS: Atrial fibrillation was associated with an adverse prognostic profile but not with an overall poorer quality of in-hospital care. Patients with atrial fibrillation had a longer total length of stay (median: 15 vs 9 days), and were at increased risk of in-hospital medical complications (adjusted relative risk = 1.48, 95% CI: 1.23–1.79) and recurrent stroke (adjusted hazard ratio = 1.30, 95% CI: 0.93–1.82) when compared with patients without atrial fibrillation. The adjusted hazard ratios for 30 days and one year mortality were 1.55 (95% CI: 1.20–2.01) and 1.55 (95% CI: 1.30–1.85), respectively. Patients not eligible to oral anticoagulant treatment had an increased risk of recurrent stroke (adjusted hazard ratio = 1.92, 95% CI: 1.19–3.11). CONCLUSION: Atrial fibrillation is associated with a poor outcome among patients with ischemic stroke particularly among patients, who are not eligible to oral anticoagulant treatment. |
format | Text |
id | pubmed-2943164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29431642010-09-23 Atrial fibrillation in patients with ischemic stroke: A population-based study Thygesen, Sandra Kruchov Frost, Lars Eagle, Kim A Johnsen, Søren Paaske Clin Epidemiol Original Research BACKGROUND: Atrial fibrillation is a major risk factor for ischemic stroke. However, the prognostic impact of atrial fibrillation among patients with stroke is not fully clarified. We compared patient characteristics, including severity of stroke and comorbidity, quality of in-hospital care and outcomes in a cohort of first-time ischemic stroke patients with and without atrial fibrillation. METHODS: Based on linkage of public medical databases, we did a population-based follow-up study among 3,849 stroke patients from the County of Aarhus, Denmark admitted in the period of 2003–2007 and prospectively registered in the Danish National Indicator Project. RESULTS: Atrial fibrillation was associated with an adverse prognostic profile but not with an overall poorer quality of in-hospital care. Patients with atrial fibrillation had a longer total length of stay (median: 15 vs 9 days), and were at increased risk of in-hospital medical complications (adjusted relative risk = 1.48, 95% CI: 1.23–1.79) and recurrent stroke (adjusted hazard ratio = 1.30, 95% CI: 0.93–1.82) when compared with patients without atrial fibrillation. The adjusted hazard ratios for 30 days and one year mortality were 1.55 (95% CI: 1.20–2.01) and 1.55 (95% CI: 1.30–1.85), respectively. Patients not eligible to oral anticoagulant treatment had an increased risk of recurrent stroke (adjusted hazard ratio = 1.92, 95% CI: 1.19–3.11). CONCLUSION: Atrial fibrillation is associated with a poor outcome among patients with ischemic stroke particularly among patients, who are not eligible to oral anticoagulant treatment. Dove Medical Press 2009-08-09 /pmc/articles/PMC2943164/ /pubmed/20865087 Text en © 2009 Thygesen et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Thygesen, Sandra Kruchov Frost, Lars Eagle, Kim A Johnsen, Søren Paaske Atrial fibrillation in patients with ischemic stroke: A population-based study |
title | Atrial fibrillation in patients with ischemic stroke: A population-based study |
title_full | Atrial fibrillation in patients with ischemic stroke: A population-based study |
title_fullStr | Atrial fibrillation in patients with ischemic stroke: A population-based study |
title_full_unstemmed | Atrial fibrillation in patients with ischemic stroke: A population-based study |
title_short | Atrial fibrillation in patients with ischemic stroke: A population-based study |
title_sort | atrial fibrillation in patients with ischemic stroke: a population-based study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943164/ https://www.ncbi.nlm.nih.gov/pubmed/20865087 |
work_keys_str_mv | AT thygesensandrakruchov atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy AT frostlars atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy AT eaglekima atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy AT johnsensørenpaaske atrialfibrillationinpatientswithischemicstrokeapopulationbasedstudy |